In this article, we describe a pharmacogenetics tactic that permits to selectively and reversibly inactivate LC neurons applying Designer Receptors Solely Activated by Designer Drugs (DREADD). We demonstrate which the expression from the hM4Di DREADD might be limited to noradrenergic LC neurons and that the amount of LC inhibition is often altered … Read More